Poonawalla's clear shot at access for all via route social

Cyrus S Poonawalla, chairman of Serum Institute of India, has created a legacy where business and social impact go hand in hand. His vaccines have saved over 30 million lives worldwide. The institute's founding values of affordability, quality, and access continue to guide its global efforts. The Villoo Poonawalla Foundation also drives philanthropy in healthcare, education, and community development.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Zf6gNs4
via IFTTT

Read More

Mankind Pharma’s Rx for success: Aatmanirbhar push, affordable care

Mankind Pharma, guided by Ramesh and Rajeev Juneja, is a leading Indian pharmaceutical firm. The company focuses on mass-market drugs and has expanded into chronic and specialty treatments. With over 75% of manufacturing in-house, Mankind Pharma emphasizes quality, affordability, and accessibility. They are investing in innovation and digital capabilities to meet growing healthcare needs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gnfC5sd
via IFTTT

Read More

Alembic Pharma gets USFDA nod for generic cancer, arthritis injection

Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic methotrexate injection, used to treat multiple cancers and arthritis conditions. The approval covers key dosage formats and confirms therapeutic equivalence to the reference drug by Hospira, enabling Alembic to market the injectable in the US. Methotrexate is widely used for treating cancers such as leukemia, osteosarcoma and breast cancer, as well as conditions like rheumatoid arthritis and severe psoriasis.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gCi15TF
via IFTTT

Read More

Eye on aspirational India, medical tourism, Max Healthcare steps up bed capacity expansion

Max Healthcare Institute Ltd is expanding capacity to 10,000 beds over the next 3–4 years, investing ₹4,000–5,000 crore to meet rising domestic demand and boost medical tourism.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tGoLmXP
via IFTTT

Read More

Dr Reddy's gets nod to roll out generic oral semaglutide drug

"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to Novo Nordisk's oral semaglutide (Rybelsus brand). Based on this clinical evidence, our product has received regulatory approval in India under the biosimilar regulatory pathway," a company spokesperson said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ni8MIN3
via IFTTT

Read More

Iran war impact: Essential drugs may cost up to 5% more, for now

The immediate net consumer impact could be 3-5% higher prices, or roughly similar to what consumers paid before the late-September cuts in GST rates. The industry expects the price increase to be in place for 3-4 months, with a rollback option once input costs stabilise.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/eh2Jf8A
via IFTTT

Read More

KKR-backed Baby Memorial to acquire 60% stake in Star Hospitals for ₹1,800 crore

Baby Memorial Hospital will acquire around 60% stake in the Hyderabad hospital chain's parent company, Unimed Healthcare.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/c2ByIzk
via IFTTT

Read More